Tech Anatomy

Dans cet épisode de Tech Anatomy, nous plongeons au cœur de l'Explore IA Academy, un programme novateur d'acculturation à l'intelligence artificielle générative développé par le laboratoire Takeda. À travers trois saisons d'évolution, nous découvrons comment l'entreprise a réussi à lever les réticences initiales et à transformer la peur de la technologie en un engouement massif au sein de ses équipes. Du choix stratégique de l'outil Copilot au déploiement de cas d'usage pratico-pratiques, cet échange met en lumière les facteurs clés de succès pour réussir une transformation digitale collaborative, humaine et centrée sur la création de valeur pour les professionnels de santé et les patients.

Sujets abordés :
La genèse de l'Explore IA Academy et l'ambition initiale de démystifier l'IA générative en milieu pharmaceutique.

Le choix de la saison 2 de se focaliser sur des outils du quotidien (Copilot sur Teams et Outlook) plutôt que sur une approche par métiers.

L'importance du format "pratico-pratique" et l'analyse de cas d'usage concrets (comptes-rendus automatisés, traduction de slides, transcription en format podcast).

Les indicateurs de succès du programme, basé sur le volontariat, avec 75 % des collaborateurs du siège formés.

La feuille de route pour 2026 (Saison 3) : l'ouverture du programme aux équipes terrain et l'intégration des nouvelles actualités de l'IA.

La création d'une communauté d'une trentaine d'ambassadeurs IA internes pour identifier les besoins métiers et co-créer des agents spécifiques.

Conseils pratiques sur les pièges à éviter (vouloir aller trop vite) et l'importance de créer un espace de liberté, sans jugement, pour encourager l'apprentissage continu.

Crédit :
Production : MedShake Studio
Animation : Anca Petre

Abonnez-vous à la newsletter Tech Anatomy :
https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7117418963067658241

Suivez Anca sur LinkedIn pour plus de tips et ressources gratuites :
https://www.linkedin.com/in/ancapetre/

Groupe WhatsApp — tips IA santé :
https://chat.whatsapp.com/CMdYp3pfcRrBX9Qxo2sKAz

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode of Tech Anatomy, we sit down with Dr. Amar Shah, a forensic psychiatrist and a leading global voice in healthcare quality improvement. Together, we explore how to transform the culture of massive healthcare organizations by empowering frontline staff and fully embedding patient voices into governance. From real-world experiments using Generative AI and AI scribes to tackle clinician burnout, to restructuring hospital data systems around frontline needs, this conversation provides a pragmatic roadmap for shifting from rigid compliance to a true culture of learning and co-production in healthcare.

Topics Covered:
The core leadership behaviors required to foster a culture of quality improvement in healthcare.

True co-production: How East London NHS embedded patients into every interview panel, training, and commercial decision.

Key learnings from piloting Generative AI in mapping complex improvement theories and building measurement plans.

The dangerous risks of algorithmic bias and data disparity when AI tools lack local validation and population diversity.

Shifting the focus from merely reducing burnout with AI scribes to actively building "joy in work" through team autonomy.

Demystifying healthcare analytics: Transitioning data to the cloud, aligning metrics by clinical teams, and democratizing access.

The vital need for "constancy of purpose" and why leaders must test, learn, and adapt rather than forcing top-down rollouts.

Credits :
Production : MedShake Studio
Animation : Anca Petre

Subscribe to the Tech Anatomy newsletter:
https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7117418963067658241

Follow Anca on LinkedIn for more tips and free resources:
https://www.linkedin.com/in/ancapetre/

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, recorded right after the closing of HIMSS Europe 2026 in Copenhagen, with Hal Wolf we are diving into the major trends shaping the future of digital health. From the pragmatic shift in AI deployment under the European AI Act to the massive infrastructure investments across European nations, we analyze how technology is moving from mere concept to tangible impact. The conversation highlights the urgent need for new toolsets to tackle growing chronic diseases and severe global workforce shortages, while emphasizing why breaking down national data silos through the European Health Data Space is vital for the future of population health.

Topics covered in this episode:
The transition of AI from a hype curve to pragmatic, real-world deployment in healthcare operations.

The impact of European regulations, specifically the AI Act and GDPR, on global innovation.

The duality of deploying advanced AI tools while simultaneously establishing foundational electronic medical records in countries like Italy, Germany, and France.

The global healthcare workforce crisis and why the traditional encounter-based paradigm is mathematically unsustainable.

The evolution of the European Health Data Space (EHDS) and the critical importance of cross-border data liquidity.

The foundational role of trust in data governance to prevent the re-emergence of healthcare data silos.

A forward-looking glance at what to expect for HIMSS Europe 2027 in Barcelona.

Credits :
Production : MedShake Studio
Animation : Anca Petre

Subscribe to the Tech Anatomy newsletter:
https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7117418963067658241

Follow Anca on LinkedIn for more tips and free resources:
https://www.linkedin.com/in/ancapetre/

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, we explore the transformation of clinical trials through digital endpoints and connected sensors. Traditionally reliant on sporadic hospital visits and subjective self-reports, medical studies are now being enriched with continuous, ultra-precise data captured in the patient's daily life. From the long journey of regulatory validation with the FDA and EMA to the importance of Design Thinking in creating solutions that patients actually want to wear, this conversation highlights how technology is bridging the gap between the clinic and reality, while significantly reducing the burden on participants and their caregivers.

Topics covered:
The limitations of traditional clinical trials and how digital endpoints bring objective precision.

The complex, long-term pathway (sometimes taking over a decade) to get a new digital measurement accepted by regulatory bodies.

A concrete case study: measuring stride and walking metrics in Duchenne Muscular Dystrophy.

Shifting the mindset regarding the FDA and EMA: moving from fear to an open, collaborative dialogue.

Data safety and device validation: why consumer-grade wearables aren't ready for official clinical data collection.

The unexpected parallels between running a Formula 1 team and managing a clinical trial (teamwork, passion, and continuous innovation).

Using Design Coaching and user-centric processes to design digital tools tailored to patients' and doctors' real needs.

Future outlooks: reducing the required sample size for trials, leveraging telemedicine, and lowering the logistical burden on caregivers.

Credits :
Production : MedShake Studio
Animation : Anca Petre

Subscribe to the Tech Anatomy newsletter:
https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7117418963067658241

Follow Anca on LinkedIn for more tips and free resources:
https://www.linkedin.com/in/ancapetre/

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, we dive into the "New Space" frontier with James Kingsnorth, a scientist at Tumbleweed. We explore how removing the "noise" of gravity allows pharmaceutical and biotech companies to discover biological structures that are impossible to replicate on Earth. From the success of Merck's Keytruda in microgravity to the creation of complex 3D organoids, this conversation highlights how orbital research is no longer a distant dream but a practical, accessible tool for modern science.
James explains how Tumbleweed is lowering the barriers to entry by replacing years of bureaucratic paperwork and ISS backlogs with a streamlined "plug-and-play" satellite service. We discuss the radical cost reductions in space access and why the next decade of drug manufacturing might just happen 400 kilometers above our heads.

Subjects Covered:
The Science of Zero-G: How removing convection and sedimentation leads to more uniform protein crystals and complex 3D structures.

Case Study (Keytruda): How Merck used microgravity to refine drug delivery, reducing treatment time from 60 minutes to 60 seconds.

Accelerated Aging: Using the harsh environment of space as a "time machine" to study immunology and disease progression in days rather than years.

Democratizing Access: How SpaceX and reusable rockets have plummeted the cost of research per kilogram.

The "Pod" Concept: Tumbleweed’s isolated, pre-certified hardware that removes the need for complex safety certifications.

The Future of Space Manufacturing: The transition from human-led experiments on the ISS to autonomous, miniaturized orbital labs.

The Return Journey: The logistics of de-orbiting experiments and recovering data for terrestrial application.

Credits :
Production : MedShake Studio
Animation : Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.